SINGAPORE (Aug 17): TPG Capital Asia, the Asian investment platform of global alternative asset firm TPG, has today completed its acquisition of Quest Laboratories, a Singapore-based medical laboratory.

This acquisition is a part of TPG’s A$279 million ($279 million) purchase of Healthscope Limited’s Asian pathology laboratories that operate under the brand “Quest Laboratories” in Singapore and Vietnam, as well as “Gribbles Pathology” in Malaysia.

Quest Laboratories is a full-service private laboratory, which is to be dually accredited by the College of American Pathologists and the Singapore Accreditation Council. It also serves specialist doctors, general practitioners, as well as integrated healthcare providers with a full suite of laboratory tests.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook